Mike Hollan

Ryan Quigley, CEO of Inizio, discusses how his experience as Chief Operating Officer shaped his journey to CEO.

The new members include individuals who have ties to fringe medical communities.

Updates to its policies have made FDA’s CRLs a key talking point.

The new administration has a different perspective of vaccines than the previous administration, causing confusion with the public.

Key points from our recent webinar on the President’s MFN order.

The company plans to switch to a partner-model for international markets.

The President issued a memo directing HHS and FDA to enforce strict regulations against potentially misleading advertising.

The agency noted ongoing safety violations at the location.

Executives are exploring various strategies to prepare for an uncertain pricing environment in the coming months and years.

The company says addressing the issues raised in the CRL could take years.

The list prevents the import of ingredients from potentially dangerous facilities.

WHO designates GLP-1 medications for diabetes as essential, aiming to improve access and affordability for patients worldwide.

Marc Stapley, CEO of Veracyte, reviews upcoming developments in the diagnostic space.

These drugs have quickly become household names due to their popularity as weight loss medications.

The two companies issued statements detailing the number of studies about the vaccines’ impact.

As more companies announce layoffs and other restructuring plans, industry experts are asking what will happen next.

The OSE Immunotherapeutics CEO discusses recent develops with this potentially game-changing space in oncology.

Marc Stapley, CEO of Veracyte, explains how investors are reacting to recent advancements in cancer care.

Noah Nasser discusses how data silos cause complications with researchers.

The company pointed the President to existing published research and pledged to post more to its site.

Marc Stapley, CEO of Veracyte, discusses the importance of ongoing evidence collection.

As the GLP market begins to settle, pharma companies and investors are looking to predict what comes next.

The feature will be available on the company’s platform Nuro.

Noah Nasser discusses how new technologies are changing the data landscape.

Marc Stapley, CEO of Veracyte, discusses new approaches to diagnostics and how its transforming cancer care.

Noah Nasser discusses one of the most critical components of working with RWD.

Michael Grosberg discusses the issues that need to be addressed to bring drug prices down for patients.

Derrick Gastineau discusses the importance of finding the right spaces to ensure patients see accurate information about medications.

Lawyers for Monarez argue that only the president can fire her and that she has no plans to resign.

Derrick Gastineau discusses the importance of patients’ hearing stories from other patients.